OGD Perspectives Gary J. Buehler, R.Ph. Director, Office of Generic Drugs October 26, 2005 GPhA Fall Technical Conference FDA/GPhA Fall Technical Conference Topics Productivity…
Update from the Office of Generic Drugs Gary J. Buehler, R.Ph. Director, Office of Generic Drugs Center for Drug Evaluation and Research Food & Drug Administration March…
Risk-Based CMC Review - OGD Perspective Gary J. Buehler, R.Ph. Director Office of Generic Drugs July 21, 2004 Advisory Committee for Pharmaceutical Science Manufacturing…